News and Media

Latest News Release
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

Top feature box IMAGE ONLY - COMPANY NEWS

Company News

Cardinal Health Names Carrie Cox to Board of Directors
12/02/2009

DUBLIN, Ohio, Dec. 2, 2009 /PRNewswire-FirstCall/ — Cardinal Health today announced that Carrie Cox will serve on the company's board of directors, effective immediately.

Cox, 52, most recently served as executive vice president and president of global pharmaceuticals at Schering-Plough Corp. She completed her tenure with the company at the close of its merger with Merck last month.

Prior to her term at Schering-Plough, Cox served as president of Pharmacia Corp.'s global pharmaceutical business. She had joined Pharmacia's predecessor company, Pharmacia & Upjohn, in 1997 and held a number of positions of increasing responsibility there.

"Carrie brings an extraordinary range of experiences from her 30 years in biopharmaceuticals and health care," said George S. Barrett, chairman and chief executive officer of Cardinal Health. "We are very excited to be able to draw on her perspectives and insights as we continue to execute on our strategic vision."

Cox has received numerous industry awards, and FORTUNE magazine named her to its list of the "50 Most Powerful Women in Business" on six separate occasions, including five consecutive years since 2005. She is a member of the board of directors of Texas Instruments, a member of the Health Policy and Management Executive Council at the Harvard School of Public Health and a member of the Board of Overseers of the University of Pennsylvania Museum of Archaeology and Anthropology.

Cox received a Bachelor of Science degree from the Massachusetts College of Pharmacy in 1981.


About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a Fortune 18 health care services company that improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, hospitals and ambulatory care sites focus on patient care while reducing costs, improving efficiency and quality, and increasing profitability. As one of the largest health care companies in the world, Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products to more than 40,000 locations each day. The company is also a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company supports the growing diagnostic industry by supplying medical products to clinical laboratories and operating the nation's largest network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. Cardinal Health employs more than 30,000 people worldwide. More information about the company may be found at cardinalhealth.com.

SOURCE: Cardinal Health, Inc.
Website: cardinalhealth.com

More Company News
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

04/07/2021

By Victor Crawford, Chief Executive Officer of the Pharmaceutical segment at Cardinal Health

04/07/2021

Cardinal Health (NYSE: CAH) Specialty Solutions today launched Cardinal Health™ Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve...

03/30/2021

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New York Stock Exchange. The company will...

View all company news »

* Required Fields